Stratasys Creates 3...
Health Care: Drugs
Pacira Pharmaceuticals Inc. (PCRX: NASDAQ)
$29.08 0.24 | 0.83%
05/22/13 - 04:00 PM ET
Company Income Statement
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Sales | 39.08M | 15.69M | 14.56M | 15.01M |
| Cost of Sales | 25.90M | 10.87M | 8.02M | 7.87M |
| Gross Operating Profit | 13.18M | 4.82M | 6.54M | 7.14M |
| Selling, General, and Administrative Expenses | 46.31M | 20.16M | 6.03M | 5.02M |
| Research & Development | 9.94M | 14.87M | 18.63M | 26.23M |
| Operating Income before D & A (EBITDA) | -43.06M | -30.21M | -18.12M | -24.12M |
| Depreciation & Amortization | 6.24M | 5.87M | 4.25M | 4.43M |
| Interest Income | 275.00K | 255.00K | 146.00K | 77.00K |
| Other Income - Net | -1.45M | 298.00K | -34.00K | 367.00K |
| Special Income / Charges | 0.00 | -3.02M | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | -50.47M | -38.55M | -22.26M | -28.10M |
| Interest Expense | 1.81M | 4.78M | 4.89M | 3.60M |
| Pre-Tax Income | -52.28M | -43.33M | -27.15M | -31.71M |
| Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | -52.28M | -43.33M | -27.15M | -31.71M |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | -52.28M | -43.33M | -27.15M | -31.71M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | -52.28M | -43.33M | -27.15M | -31.71M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-52.28M | -40.31M | -27.15M | -31.71M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | -52.28M | -43.33M | -27.15M | -31.71M |
| Basic EPS from Continuing Ops. | -1.72 | -2.64 | -47.29 | -55.32 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | -1.72 | -2.64 | -47.29 | -55.32 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | -1.72 | -2.64 | -47.29 | -55.32 |
| Basic Normalized Net Income/Share | -1.72 | -2.46 | -47.29 | -55.32 |
| EPS fr Continuing Ops. | -1.72 | -2.64 | -47.29 | -55.32 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | -1.72 | -2.64 | -47.29 | -55.32 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | -1.72 | -2.64 | -47.29 | -55.32 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-1.72 | -2.46 | -47.29 | -55.32 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with PCRX
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorEarnings Short Squeeze Play...
- UserNew
- ContributorUnder-$10 Setting Up To Tra...
- UserDayTrading Test 1
- Contributor10 Best-Performing IPOs of ...
- Contributor10 Health-Care Stocks Outpe...
Latest PCRX Headlines from TheStreet
- Top Insider Trades: AGCO ECHO PCRX TWER 03.26.13 | 04:03 pm
- Top Insider Trades: CHDN, PCRX, ULTA, PMBC 03.22.13 | 08:03 am
- 'Mad Money' Lightning Round: Stick With Cummins, Sell Micron 03.14.13 | 06:03 am
- Cramer's 'Mad Money' Recap: A Resting Bull Market 03.13.13 | 07:03 pm
- Pacira Pharmaceuticals Inc. Stock Upgraded (PCRX) 03.11.13 | 05:03 am
- 4 Stocks Rising on Unusual Volume 02.01.13 | 03:02 pm
- Top Insider Trades: BAC LGND PCRX BDBD 01.28.13 | 08:01 am
- 9 Hedge Fund Favorites With Barclays Buy Ratings Test 1 11.19.12 | 06:11 am
- 9 Hedge Fund Favorites With Barclays Buy Ratings 11.16.12 | 04:11 pm
- 7 Stocks Ripping Higher on Huge Volume 06.11.12 | 01:06 pm
Press Releases for PCRX
- Analysis Of Postsurgical Pain Management Finds Opioid-Related Adverse Events Drive Longer Hospital Stays, Greater Cost And Higher Likelihood Of Readmission - Business Wire 03.27.13 | 06:03 am
- Pacira Pharmaceuticals, Inc. To Present At The Barclays Global Healthcare Conference - Business Wire 03.06.13 | 06:03 am
- Pacira Pharmaceuticals, Inc. Announces Timing For 2012 Financial Results Webcast And Conference Call - Business Wire 02.28.13 | 06:02 am
- Pacira Pharmaceuticals, Inc. To Present At The Cowen And Company 33rd Annual Health Care Conference - Business Wire 02.25.13 | 06:02 am
- Pacira Pharmaceuticals, Inc. Announces Pricing Of $110 Million Private Offering Of Convertible Senior Notes - Business Wire 01.17.13 | 08:01 am
- Pacira Pharmaceuticals, Inc. Announces Proposed Offering Of $100 Million Of Convertible Senior Notes - Business Wire 01.15.13 | 04:01 pm
- New Publication Suggests Higher Opioid Use In The Postsurgical Setting May Be Linked To Extended Hospital Stay And Increased Cost Of Care - Business Wire 12.18.12 | 06:12 am
- Http://www.aratanatherapeutics.com/ - Business Wire 12.06.12 | 06:12 am
- Pacira Pharmaceuticals, Inc. To Present At The 24th Annual Piper Jaffray Healthcare Conference - Business Wire 11.20.12 | 06:11 am
- New Data Demonstrate Reduction In Opioid Use, Hospital Cost And Length Of Stay With EXPAREL As The Foundation Of A Multimodal Regimen - Business Wire 11.20.12 | 06:11 am
Partner Headlines for PCRX
- UPDATE: Wedbush Raises PT to $32 on Pacira Pharmaceuticals on Long-Term Outlook - Benzinga 03.07.13 | 01:03 pm
- 3 Outperforming Small Caps Bought Up By Insiders And Hedge Funds - Seeking Alpha 04.13.12 | 07:04 pm
- Noteworthy Insider Buys In The Healthcare Sector Last Week - Seeking Alpha 11.29.11 | 08:11 am
- How Will Congress' Budget Cuts Affect Health Care? - Benzinga 11.21.11 | 01:11 pm
- Decision Due For Pacira's Flagship Drug EXPAREL - Seeking Alpha 10.31.11 | 08:10 am
- Biotech Catalysts for Third Quarter - Seeking Alpha 06.24.11 | 06:06 pm
- 6 Stocks With Recent CFO Buys - Seeking Alpha 02.25.11 | 08:02 am
- 7 Diverse U.S. IPOs Test Investor Appetites This Week - Seeking Alpha 02.13.11 | 06:02 am
- RPT-IPO VIEW-Biotech IPO spurt to test U.S. market - Reuters 02.06.11 | 10:02 am
- IPO VIEW-Biotech IPO spurt to test U.S. market - Reuters 02.04.11 | 07:02 pm
